APTENSIO XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Rhodes Pharmaceuticals L.p.. The primary component is Methylphenidate Hydrochloride.
| Product ID | 42858-407_9468380f-2590-4c7a-9451-81776fa2cfaf |
| NDC | 42858-407 |
| Product Type | Human Prescription Drug |
| Proprietary Name | APTENSIO XR |
| Generic Name | (methylphenidate Hydrochloride) |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-04-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205831 |
| Labeler Name | Rhodes Pharmaceuticals L.P. |
| Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
| Active Ingredient Strength | 60 mg/1 |
| Pharm Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2015-04-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205831 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-04-17 |
| Ingredient | Strength |
|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | 60 mg/1 |
| SPL SET ID: | 5adedc01-ebf0-11e3-ac10-0800200c9a66 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42858-401 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-402 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-403 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-404 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-405 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-406 | APTENSIO XR | (methylphenidate hydrochloride) |
| 42858-407 | APTENSIO XR | (methylphenidate hydrochloride) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() APTENSIO XR 85838161 4822493 Live/Registered |
Rhodes Pharmaceuticals L.P. 2013-02-01 |